Drug Design and Medicinal Chemistry (ICDDMC-26)

This track will explore novel methodologies in drug design, focusing on innovative approaches that enhance the efficacy and safety of therapeutic agents. Emphasis will be placed on the integration of computational techniques and experimental validation.

This session will cover the latest advancements in molecular modeling and simulation techniques that facilitate drug discovery. Participants will discuss the application of these tools in predicting drug interactions and optimizing lead compounds.

This track will highlight cutting-edge synthetic methods employed in the development of new pharmaceuticals. Discussions will focus on green chemistry approaches and the synthesis of complex molecules with therapeutic potential.

This session will delve into the pharmacological aspects of drug action, examining the mechanisms by which drugs exert their effects. Researchers will present findings on receptor interactions and signaling pathways relevant to drug efficacy.

This track will focus on the intersection of chemical biology and drug discovery, emphasizing how biological insights can inform medicinal chemistry. Topics will include target identification and validation, as well as the role of chemical probes.

This session will explore the development of targeted therapies aimed at specific disease mechanisms, particularly in oncology and chronic diseases. Discussions will include the challenges and successes in personalizing treatment regimens based on genetic profiles.

This track will examine recent innovations in pharmaceutical formulations that enhance drug delivery and bioavailability. Topics will include novel excipients, delivery systems, and the role of nanotechnology in pharmaceuticals.

This session will focus on the application of computational chemistry techniques in drug development processes. Participants will discuss quantitative structure-activity relationship (QSAR) modeling and virtual screening methodologies.

This track will highlight the role of natural products as sources of new drug candidates and their importance in medicinal chemistry. Presentations will cover extraction, modification, and synthesis of bioactive compounds from natural sources.

This session will address the regulatory landscape surrounding drug development, focusing on the requirements for clinical trials and market approval. Experts will discuss the implications of regulatory guidelines on medicinal chemistry research.

This track will explore the ethical implications of drug research and development, including issues related to clinical trials and access to medications. Discussions will aim to foster a responsible approach to pharmaceutical innovation.